BenevolentAI
Chanasak Winn Mahankarat is an Advanced Software Engineer at BenevolentAI since September 2022, where responsibilities include designing and implementing data engineering tools, leading migration initiatives, and developing pipelines for chemical databases and biomedical literature. Previous experience includes roles at BenevolentAI as a Software Engineer, Imperial College London as an Undergraduate Teaching Assistant, and internships at BenevolentAI, GE Digital, and Heteronomics. Chanasak holds a Master's degree in Biomedical Engineering and Computational Bioengineering from Imperial College London, along with notable academic foundations from Singapore and Thailand.
This person is not in any offices
BenevolentAI
8 followers
BenevolentAI combines advanced AI and machine learning with cutting edge science to decipher complex disease biology, generate novel insights and discover more effective medicines. Our unique computational R&D platform spans every step of the drug discovery process, powering an in-house pipeline of 25+ drug programmes from early discovery towards clinical phases. With several successful collaborations with leading pharmaceutical organisations, we are also the only AI-drug discovery company with a clinically validated approach, discovering a leading repurposed drug candidate for COVID-19. BenevolentAI is headquartered in London with a research facility in Cambridge (UK) and a further office in New York, with a team of over 300 world-leading scientists and technologists progressing its mission to reinvent drug discovery and advance life-changing drugs through to the clinic.